Overview of current chelation practices
<p>Deferoxamine (DFO) is reference standard therapy for transfusional iron overload since the 1980s. Although it is a highly effective iron chelator, the compliance problem to subcutaneous administration of DFO remains as the major problem. The oral chelator Deferiprone (DFP) has no marketing licenc...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2011-12-01
|
| Serija: | Thalassemia Reports |
| Teme: | |
| Online dostop: | http://www.pagepressjournals.org/index.php/thal/article/view/300 |
| Oznake: |
Brez oznak, prvi označite!
|